Clinical trial
Symbicort Turbuhaler 30/60 Clinical Experience Investigation
NCT01232348 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Symbicort Turbuhaler 30/60 Clinical Experience Investigation
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- October 31, 2011
- Enrollment
- 3,643 (actual)
- Sites
- 47
Conditions
As the registry lists them; a condition with its own page is linked.
bronchial asthma